| Literature DB >> 35846007 |
Antonio Palomba1, Riccardo Melis1, Grazia Biosa1, Angela Braca1, Salvatore Pisanu1, Stefania Ghisaura1, Christian Caimi2, Ilaria Biasato2, Sara Bellezza Oddon2, Laura Gasco2, Genciana Terova3, Federico Moroni3, Micaela Antonini3, Daniela Pagnozzi1, Roberto Anedda1.
Abstract
The sustainable development of modern aquaculture must rely on a significant reduction of the fish meal (FM) used in aquafeed formulations. However, FM substitution with alternative ingredients in diets for carnivorous fish species often showed reduced nutrient absorption, significantly perturbed metabolisms, and histological changes at both hepatic and intestinal levels. In the present study, rainbow trout (Oncorhynchus mykiss) were fed three different experimental aquafeeds. A control diet with higher FM content (27.3%) than two test formulations in which FM was substituted with two more sustainable and promising alternatives: insect meal (Hermetia illucens larvae = 10.1%, FM = 11.6%) and poultry by-products meal (PBM = 14.8%; FM = 11.7%). Combined metabolomics and proteomics analyses of fish liver, together with histological examination of liver and intestine demonstrated that a well-balanced formulation of nutrients in the three diets allowed high metabolic compatibility of either substitution, paving the way for a deeper understanding of the impact of novel raw materials for the fish feed industry. Results show that the main metabolic pathways of nutrient absorption and catabolism were essentially unaltered by alternative feed ingredients, and also histological alterations were negligible. It is demonstrated that the substitution of FM with sustainable alternatives does not have a negative impact on fish metabolism, as long as the nutritional requirements of rainbow trout are fulfilled.Entities:
Keywords: NMR-based metabolomics; hepatic metabolism; insect meal; poultry by-products meal; proteomics; sustainable aquaculture
Year: 2022 PMID: 35846007 PMCID: PMC9276982 DOI: 10.3389/fphys.2022.920289
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1Workflow in the proteomics, metabolomics and histology experiments.
Shotgun proteomics analysis metrics. SD, standard deviation; CV, coefficient of variation; C, control diet; I, insect meal diet; P, poultry by-products meal diet.
| Groups | Peptides | Proteins | KEGG orthologs | Protein families | ||||
|---|---|---|---|---|---|---|---|---|
| Mean ± SD | CV (%) | Mean ± SD | CV (%) | Mean ± SD | CV (%) | Mean ± SD | CV (%) | |
| All samples | 29,814 ± 1,326 | 4.4 | 4,222 ± 111 | 2.6 | 2,042 ± 46 | 2.3 | 1,057 ± 20 | 1.9 |
| C | 30,008 ± 596 | 2.0 | 4,248 ± 54 | 1.3 | 2,054 ± 21 | 1.0 | 1,065 ± 9 | 0.8 |
| I | 29,257 ± 2,220 | 7.6 | 4,170 ± 184 | 4.4 | 2,021 ± 77 | 3.8 | 1,046 ± 32 | 3.2 |
| P | 30,177 ± 340 | 1.1 | 4,248 ± 18 | 0.4 | 2,051 ± 10 | 0.5 | 1,060 ± 3 | 0.3 |
FIGURE 2Principal component analysis (PCA) scores plots related to quantitative data of proteins (A) KEGG orthologs (B) and protein families (C) obtained from liver of rainbow trout subjected to different feed treatment (C: control diet, green; I: insect meal diet, red; P: poultry by-products meal diet, blue). Colored ellipses describe the T2-Hotelling 95% confidence intervals of each dietary group.
FIGURE 3Principal component analysis (PCA) scores plots related to 1D 1H NMR spectra of liver aqueous (A) and lipid extracts (B) and from muscle lipid fraction (C) from rainbow trout fed different experimental diets (C: control diet, green; I: insect meal diet, red; P: poultry by-products meal diet, blue). Colored ellipses describe the T2-Hotelling 95% confidence intervals of each dietary group.
Main metabolic pathways identified in trout liver as results of the integrated metabolomic and proteomic joint pathway analysis. Pathways are ranked considering hits percentage (Hits%) and filtered taking False Discovery Rate (FDR) < 0.05 and Hits > 5 as minimum thresholds.
| Pathway | Total | Hits | Hits (%) |
| FDR |
|---|---|---|---|---|---|
| Fatty acid metabolism | 71 | 26 | 36.62 | 5.77E-11 | 2.58E-09 |
| Valine, leucine and isoleucine degradation | 105 | 36 | 34.29 | 1.06E-13 | 9.46E-12 |
| Aminoacyl-tRNA biosynthesis | 22 | 7 | 31.82 | 1.92E-03 | 1.27E-02 |
| Ether lipid metabolism | 29 | 9 | 31.03 | 5.39E-04 | 4.39E-03 |
| Fatty acid elongation | 51 | 15 | 29.41 | 1.64E-05 | 2.10E-04 |
| Glutathione metabolism | 76 | 22 | 28.95 | 2.38E-07 | 4.27E-06 |
| Citrate cycle (TCA cycle) | 78 | 22 | 28.21 | 3.94E-07 | 6.41E-06 |
| Glycolysis/Gluconeogenesis | 96 | 27 | 28.13 | 1.97E-08 | 5.03E-07 |
| Alanine, aspartate and glutamate metabolism | 98 | 27 | 27.55 | 3.18E-08 | 6.55E-07 |
| Biosynthesis of unsaturated fatty acids | 53 | 14 | 26.42 | 1.16E-04 | 1.09E-03 |
| beta-Alanine metabolism | 65 | 17 | 26.15 | 2.51E-05 | 2.81E-04 |
| Fatty acid degradation | 77 | 19 | 24.68 | 2.08E-05 | 2.48E-04 |
| Glycine, serine and threonine metabolism | 130 | 32 | 24.62 | 3.29E-08 | 6.55E-07 |
| Various types of N-glycan biosynthesis | 57 | 13 | 22.81 | 9.46E-04 | 7.06E-03 |
| Glyoxylate and dicarboxylate metabolism | 128 | 29 | 22.66 | 9.75E-07 | 1.45E-05 |
| Histidine metabolism | 62 | 13 | 20.97 | 2.15E-03 | 1.37E-02 |
| N-Glycan biosynthesis | 81 | 16 | 19.75 | 1.36E-03 | 9.34E-03 |
| Tryptophan metabolism | 117 | 23 | 19.66 | 1.41E-04 | 1.26E-03 |
| Carbon metabolism | 350 | 68 | 19.43 | 5.32E-11 | 2.58E-09 |
| Biosynthesis of cofactors | 360 | 68 | 18.89 | 1.98E-10 | 5.90E-09 |
| Propanoate metabolism | 113 | 21 | 18.58 | 6.04E-04 | 4.70E-03 |
| Cysteine and methionine metabolism | 151 | 27 | 17.88 | 2.03E-04 | 1.73E-03 |
| Pyruvate metabolism | 143 | 24 | 16.78 | 1.17E-03 | 8.34E-03 |
| Biosynthesis of amino acids | 235 | 38 | 16.17 | 1.05E-04 | 1.05E-03 |
| Amino sugar and nucleotide sugar metabolism | 174 | 25 | 14.37 | 7.92E-03 | 4.57E-02 |
| Purine metabolism | 274 | 37 | 13.50 | 4.10E-03 | 2.44E-02 |
| Biosynthesis of secondary metabolites | 1,460 | 187 | 12.81 | 1.76E-10 | 5.90E-09 |
| Metabolic pathways | 4,090 | 454 | 11.10 | 1.50E-38 | 2.69E-36 |
FIGURE 4Reconstruction of significant liver metabolic pathways identified by an integrated analysis of proteomics and metabolomics data (based on the KEGG pathway module database).
Histological changes in proximal and distal intestine and in the liver of rainbow trout fed different experimental diets. Proximal and distal intestine data are shown as mean ± standard error. Liver data are expressed as a grading scale (1 = not observed/few, 2 = medium, 3 = severe) (n = 4). ViH, villi height; ViW, villi width; SMT, submucosal layer thickness; ND, nuclear displacement; HV, hepatocytes vacuolization; NS, irregular nuclei shapes; CH, cellular hypertrophy. C, control diet; I, insect meal diet; P, poultry by-products meal diet.
| Morphological parameters | Experimental diets | ||
|---|---|---|---|
| Proximal Intestine | C | I | P |
| ViH (µm) | 731.34 ± 25.11 | 735.74 ± 54.64 | 738.45 ± 34.65 |
| ViW (µm) | 91.08 ± 3.47 | 92.24 ± 4.34 | 91.66 ± 6.35 |
| SMT (µm) | 72.32 ± 3.30 | 74.58 ± 2.81 | 71.93 ± 2.03 |
| Distal Intestine | C | I | P |
| ViH (µm) | 740.89 ± 47.25 | 736.26 ± 68.23 | 737.60 ± 96.41 |
| ViW (µm) | 88.47 ± 3.18 | 86.63 ± 3.85 | 89.28 ± 7.19 |
| SMT (µm) | 58.26 ± 1.92 | 59.76 ± 5.04 | 57.36 ± 3.86 |
| Liver | C | I | P |
| ND | 1 | 1 | 1 |
| HV | 1 | 1–2 | 1–2 |
| NS | 1 | 1–2 | 1 |
| CH | 1 | 1 | 1 |
FIGURE 5Light microscopy of proximal intestine portions of trout fed control diet (A), poultry by products meal diet (B) and insect meal diet (C). SMT, submucosal layer thickness; ViH, villi height; ViW, villi width. Hematoxylin and eosin, scale bar = 500 μm.
FIGURE 6Light microscopy of distal intestine portions of trout fed control diet (A), poultry by-products meal diet (B) and insect meal diet (C). Hematoxylin and eosin, scale bar = 100 μm.
FIGURE 7Light microscopy of liver of trout fed control diet (A), poultry by-products meal diet (B) and insect meal diet (C). Hematoxylin and eosin, scale bar = 100 μm.